Olanzapine Impurity 1 is a synthetic byproduct arising from incomplete alkylation during piperazine ring formation in olanzapine manufacturing. It retains the dibenzodiazepine core and thiazole moiety but lacks the 2-methyl substitution on the piperazine ring, resulting in a primary amine functionality at that position. This structural deviation leads to distinct chromatographic behavior and reduced antipsychotic activity compared to the parent compound. Used as an HPLC reference standard for process-related impurity profiling in olanzapine drug substance analysis.
On Request1355034-54-6
C(C)N1CCN(CC1)C=1C2=C(NC3=C(N1)C=CC=C3)SC(=C2)C
InChI=1S/C18H22N4S/c1-3-21-8-10-22(11-9-21)17-14-12-13(2)23-18(14)20-16-7-5-4-6-15(16)19-17/h4-7,12,20H,3,8-11H2,1-2H3
SFVPZMOQWVABLF-UHFFFAOYSA-N